Keywords: good, patient, reports, astrazeneca, atacand, new, analysis

Good patient reports on AstraZeneca's Atacand

Article | 04 July 2005

Print This

A new analysis of data from a study of AstraZeneca's angiotensin receptor blocker Atacand (candesartan) found that patient perception of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in